Skip to main content
Premium Trial:

Request an Annual Quote

Philips, New York Medical College to Collaborate on Computational Genomics Projects

NEW YORK (GenomeWeb) – Royal Philips today announced an expanded partnership between its Healthcare Research arm and New York Medical College (NYMC) which will focus on personalized cancer care.

Previously, NYMC has collaborated with Philips' genomics arm to develop IntelliSpace Genomics, an application built on Philips Healthsuite that offers analysis workflows for pathologists, oncologists, and researchers. The tool combines and integrates data from multiple sources including raw sequence, clinical data, longitudinal patient records, medical images, pathology data, and more.

Under the terms of the expanded partnership, scientists from Philips IntelliSpace Genomics will be located at the NYMC and share space with BioInc@NYC, the NYMC's biotechnology incubator in Valhalla, NY. The partners plan to work on computational genomics projects that will support Philips' work in personalized cancer care and result in the development of innovative solutions that can address pressing healthcare challenges, the company said.

Working from space on the NYMC campus will also enable Philips' researchers to collaborate more closely with partners at three affiliated teaching hospitals on Westchester Medical Center Health Network's (WMCHealth) campus in Valhalla, the company said.

Recently, WMCHealth launched a new precision medicine initiative that will use the IntelliSpace solution to combine genomic and clinical data to offer more tailored treatments for patients. Philips is also expanding the annotation and interpretation capabilities of the IntelliSpace platform via a partnership with clinical interpretation services provider N-of-One.

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.